Add this result to my export selection selexipag (Uptravi) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 May 2018 Indication: For the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection atezolizumab (Tecentriq) for NSCLC Source: Scottish Medicines Consortium - SMC (Remove filter) 09 July 2018 Indication: Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. Patients with EGFR activating mutations or ALK-positive tumour... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection lutetium 177Lu oxodotreotide (Lutathera) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 July 2018 Indication: Unresectable or metastatic, progressive, well differentiated (G1 and G2) somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours in adults. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection ofatumumab (Arzerra) Source: Scottish Medicines Consortium - SMC (Remove filter) Indication: Treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olanzapine long acting injection (ZypAdhera) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 August 2010 Indication: Maintenance treatment of adult patients with schizophrenia sufficiently stabilised during acute treatment with oral olanzapine. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olmesartan medoxomil (Olmetec) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 November 2003 Indication: Hypertension Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olmesartan medoxomil / amlodipine besilate / hydrochlorothiazide (Sevikar HCT) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 December 2012 Indication: In adult patients whose blood pressure is not adequately controlled on the combination of olmesartan medoxomil and amlodipine taken as dual-component formulation. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olaparib (Lynparza) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 November 2016 Indication: Monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube, ... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olmesartan medoximil / amlodipine besilate (Sevikar) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 October 2009 Indication: For treatment of essential hypertension Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection olodaterol respimat (Striverdi Respimat) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 January 2015 Indication: Maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)